169 related articles for article (PubMed ID: 9241097)
1. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels.
Cockcroft JR; Noon JP; Gardner-Medwin J; Bennett T
Br J Clin Pharmacol; 1997 Jul; 44(1):57-60. PubMed ID: 9241097
[TBL] [Abstract][Full Text] [Related]
2. Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.
McEwan JR; Benjamin N; Larkin S; Fuller RW; Dollery CT; MacIntyre I
Circulation; 1988 May; 77(5):1072-80. PubMed ID: 2452035
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP).
Wilkinson IB; McEniery CM; Bongaerts KH; MacCallum H; Webb DJ; Cockcroft JR
Br J Clin Pharmacol; 2001 Aug; 52(2):159-64. PubMed ID: 11488772
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster.
Hall JM; Siney L; Lippton H; Hyman A; Kang-Chang J; Brain SD
Br J Pharmacol; 1995 Feb; 114(3):592-7. PubMed ID: 7735685
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
6. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
[TBL] [Abstract][Full Text] [Related]
7. The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: a study using in vivo and in vitro assays in the mouse.
Tam C; Brain SD
J Mol Neurosci; 2004; 22(1-2):117-24. PubMed ID: 14742916
[TBL] [Abstract][Full Text] [Related]
8. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure.
Nakamura M; Yoshida H; Makita S; Arakawa N; Niinuma H; Hiramori K
Circulation; 1997 Mar; 95(5):1214-21. PubMed ID: 9054852
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
10. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
Yoshimoto R; Mitsui-Saito M; Ozaki H; Karaki H
Br J Pharmacol; 1998 Apr; 123(8):1645-54. PubMed ID: 9605572
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.
Collier JG; Pitcher DW
Br J Clin Pharmacol; 1980 Dec; 10(6):567-71. PubMed ID: 6110437
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats.
Shirai M; Shimouchi A; Ikeda S; Ninomiya I; Sunagawa K; Kangawa K; Matsuo H
Br J Pharmacol; 1997 Jun; 121(4):679-86. PubMed ID: 9208134
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary vasodilation to adrenomedullin: a novel peptide in humans.
Heaton J; Lin B; Chang JK; Steinberg S; Hyman A; Lippton H
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2211-5. PubMed ID: 7611471
[TBL] [Abstract][Full Text] [Related]
14. Effects of adrenomedullin and calcitonin gene-related peptide on airway and pulmonary vascular smooth muscle in guinea-pigs.
Pinto A; Sekizawa K; Yamaya M; Ohrui T; Jia YX; Sasaki H
Br J Pharmacol; 1996 Dec; 119(7):1477-83. PubMed ID: 8968558
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.
Newby DE; Sciberras DG; Mendel CM; Gertz BJ; Boon NA; Webb DJ
Br J Clin Pharmacol; 1997 May; 43(5):493-9. PubMed ID: 9159564
[TBL] [Abstract][Full Text] [Related]
16. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin-(22-52) antagonizes vasodilator responses to CGRP but not adrenomedullin in the cat.
Champion HC; Santiago JA; Murphy WA; Coy DH; Kadowitz PJ
Am J Physiol; 1997 Jan; 272(1 Pt 2):R234-42. PubMed ID: 9039014
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles.
Lang MG; Paternò R; Faraci FM; Heistad DD
Stroke; 1997 Jan; 28(1):181-5. PubMed ID: 8996509
[TBL] [Abstract][Full Text] [Related]
19. Effect of morphine on limb capacitance and resistance vessels.
Cohen RA; Coffman JD
Clin Sci (Lond); 1981 Jan; 60(1):5-9. PubMed ID: 7237924
[TBL] [Abstract][Full Text] [Related]
20. Barium reduces resting blood flow and inhibits potassium-induced vasodilation in the human forearm.
Dawes M; Sieniawska C; Delves T; Dwivedi R; Chowienczyk PJ; Ritter JM
Circulation; 2002 Mar; 105(11):1323-8. PubMed ID: 11901043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
